Tuesday, October 18, 2011 1:35:08 AM
Yes. He was the person in charge of the clinical study that AQLV "sponsored".
You will find the relevant legislation in Kenya and the US - and both laws apply to AQLV as a US Corporation conducting research in Kenya - makes the person coordinating the trial and the sponsor responsible for minimizing, reporting and trying to avert the potential adverse events of such a study.
AQLV/Mutisya didn't even apply for approval for the study, which would have been the first step in such damage avoidance.
They are not only responsible, but deeply culpable.
Again, that should be evident to anyone with a common sense of morality and a passing knowledge of regulations relating to biopharmaceutical research.
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM